FDA Approves Tioprinin for Treatment of Cystinosis
The FDA has approved Tioprinin under NDA212927 for the treatment of cystinosis.
Therapeutic Area
Therapeutic area intelligence for Cystinosis with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.